These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 28209559)
1. Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b). Buijs M; van Lienden KP; Wagstaff PG; Scheltema MJ; de Bruin DM; Zondervan PJ; van Delden OM; van Leeuwen TG; de la Rosette JJ; Laguna MP JMIR Res Protoc; 2017 Feb; 6(2):e21. PubMed ID: 28209559 [TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol. Wagstaff PG; de Bruin DM; Zondervan PJ; Savci Heijink CD; Engelbrecht MR; van Delden OM; van Leeuwen TG; Wijkstra H; de la Rosette JJ; Laguna Pes MP BMC Cancer; 2015 Mar; 15():165. PubMed ID: 25886058 [TBL] [Abstract][Full Text] [Related]
3. MRI and CT in the follow-up after irreversible electroporation of small renal masses. Buijs M; de Bruin DM; Wagstaff PG; J Zondervan P; Scheltema MJ; W Engelbrecht M; P Laguna M; van Lienden KP Diagn Interv Radiol; 2021 Sep; 27(5):654-663. PubMed ID: 34559050 [TBL] [Abstract][Full Text] [Related]
4. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study). Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201 [TBL] [Abstract][Full Text] [Related]
5. Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study. Buijs M; Zondervan PJ; de Bruin DM; van Lienden KP; Bex A; van Delden OM Urol Oncol; 2019 Mar; 37(3):183.e1-183.e8. PubMed ID: 30509869 [TBL] [Abstract][Full Text] [Related]
6. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area. Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332 [TBL] [Abstract][Full Text] [Related]
7. Upper-Urinary-Tract Effects After Irreversible Electroporation (IRE) of Human Localised Renal-Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Ablate-and-Resect Study. Wendler JJ; Pech M; Köllermann J; Friebe B; Siedentopf S; Blaschke S; Schindele D; Porsch M; Baumunk D; Jürgens J; Fischbach F; Ricke J; Schostak M; Böhm M; Liehr UB Cardiovasc Intervent Radiol; 2018 Mar; 41(3):466-476. PubMed ID: 28929209 [TBL] [Abstract][Full Text] [Related]
8. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol. van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827 [TBL] [Abstract][Full Text] [Related]
9. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial). Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890 [TBL] [Abstract][Full Text] [Related]
10. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy. van den Bos W; de Bruin DM; van Randen A; Engelbrecht MR; Postema AW; Muller BG; Varkarakis IM; Skolarikos A; Savci-Heijink CD; Jurhill RR; Zondervan PJ; Laguna Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ Eur Radiol; 2016 Jul; 26(7):2252-60. PubMed ID: 26449559 [TBL] [Abstract][Full Text] [Related]
11. Irreversible Electroporation for the Treatment of Small Renal Masses: 5-Year Outcomes. Dai JC; Morgan TN; Steinberg RL; Johnson BA; Garbens A; Cadeddu JA J Endourol; 2021 Nov; 35(11):1586-1592. PubMed ID: 33926224 [No Abstract] [Full Text] [Related]
12. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial. Scheltema MJ; van den Bos W; de Bruin DM; Wijkstra H; Laguna MP; de Reijke TM; de la Rosette JJ BMC Cancer; 2016 May; 16():299. PubMed ID: 27150293 [TBL] [Abstract][Full Text] [Related]
13. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial. Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653 [TBL] [Abstract][Full Text] [Related]
14. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial). Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813 [TBL] [Abstract][Full Text] [Related]
15. Confocal Laser Endomicroscopy for the Diagnosis of Urothelial Carcinoma in the Bladder and the Upper Urinary Tract: Protocols for Two Prospective Explorative Studies. Liem EI; Freund JE; Baard J; de Bruin DM; Laguna Pes MP; Savci-Heijink CD; van Leeuwen TG; de Reijke TM; de la Rosette JJ JMIR Res Protoc; 2018 Feb; 7(2):e34. PubMed ID: 29415874 [TBL] [Abstract][Full Text] [Related]
17. Ultrasound-guided percutaneous irreversible electroporation of hepatic and abdominal tumors not eligible for surgery or thermal ablation: a western report on safety and efficacy. Giorgio A; Amendola F; Calvanese A; Ingenito E; Santoro B; Gatti P; Ciracì E; Matteucci P; Giorgio V J Ultrasound; 2019 Mar; 22(1):53-58. PubMed ID: 30843171 [TBL] [Abstract][Full Text] [Related]
18. Minimally Invasive Percutaneous Treatment of Small Renal Tumors with Irreversible Electroporation: A Single-Center Experience. Trimmer CK; Khosla A; Morgan M; Stephenson SL; Ozayar A; Cadeddu JA J Vasc Interv Radiol; 2015 Oct; 26(10):1465-71. PubMed ID: 26250855 [TBL] [Abstract][Full Text] [Related]